Earnings call transcript: Ascendis Pharma Q4 2024 sees revenue rise
Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...
Communications of the ACM8 小时
Molecular Communications in Blood Vessels: Models, Analysis, and Enabling Technologies
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...